Skip to main content
Article thumbnail
Location of Repository

Seroepidemiology of measles in Addis Ababa Ethiopia: implications for control through vaccination

By F. Enquselassie, W. Ayele, A. Dejene, T. Messele, A. Abebe, Felicity Cutts and D. James Nokes


We undertook a representative survey of measles antibodies in Addis Ababa, Ethiopia 1994, to characterize immunity and transmission. Specific-antibody levels (IU/l) were determined by ELISA for 4654 sera from individuals aged 0–49 years (1805 <15 years) collected by stratified household-cluster sampling. The proportion seronegative (<100 IU/l) was 20% (95% CI : 16–25) in children 9–59 months old, declining to 9% (7–12) in 5–9 year olds, 5% (4–7) in 10–14 year olds, and <1% in adults. The proportion of children (<15 years old) with low-level antibody (100–255 IU/l) was 8% (7–10). Vaccination and an absence of a history of measles illness were strongly associated with low-level antibody. History of measles vaccination in 9 months to 14-year-old children was y80%. We estimate a primary vaccine failure rate of 21% (12–34) and continued high measles incidence of 22 per 100 susceptibles (19–24) per annum. Our data support the introduction of campaign vaccination in the city in 1998, although higher routine vaccine coverage is required to sustain the impact. The implications of a high prevalence of low-level antibody are discussed

Topics: RB, RA
Publisher: Cambridge University Press
Year: 2003
OAI identifier:

Suggested articles


  1. (1995). Predicting the impact of measles vaccination in England and Wales: model validation and analysis of policy options. Epidemiol Infect doi
  2. (1995). Interpretation of serological surveillance data for measles using mathematical models: implications for vaccine strategy. Epidemiol Infect doi
  3. (1995). Prevalence of measles antibody among children under 15 years of age in Santa Cruz, Bolivia: implications for vaccination strategies. Trans Royal Soc Trop Med Hyg doi
  4. (1998). Measles antibody levels in a vaccinated population in Brazil. Trans Royal Soc Trop Med Hyg doi
  5. (2001). The seroepidemiology of measles in Western Europe. Epidemiol Infect doi
  6. (1994). vaccination campaign. CDR
  7. (2000). The epidemiology of measles in Poland: prevalence of measles virus antibodies in the population. Epidemiol Infect doi
  8. (1999). Modeling the impact of subclinical measles transmission in vaccinated populations with waning immunity. doi
  9. (2000). Protective titres of measles neutralising antibody. doi
  10. (1999). An investigation of measles elimination in Taiwan: seroepidemiology and modelling.
  11. (2001). Measles virus strains circulating in Ethiopia in 1998–1999: Molecular characterisation using oral fluid samples and identification of a new genotype. doi
  12. (2001). Has oral fluid the potential to replace serum for the evaluation of population immunity levels? A study of measles, rubella and hepatitis B in rural Ethiopia. Bull WHO
  13. (2000). Sero-epidemiology of rubella in the urban population of Addis Ababa, Ethiopia. Epidemiol Infect doi
  14. (1998). A comparison of oral fluid and serum for the detection of rubella-specific antibodies in a community study in Addis Ababa, Ethiopia. Trop Med Int Health doi
  15. (1998). and sex-specific HIV-1 prevalence in the urban community setting of Addis Ababa, Ethiopia. Aids doi
  16. (1984). Population Housing Census Commission. The doi
  17. (1995). Report of a joint national review of the expanded programme on immunization (E.P.I.). Addis Ababa: Ministry of Health,
  18. (1999). Department. Supplementary activities aimed at achieving measles control in Ethiopia for 1999–2000. Addis Ababa: Family Health Department, Ministry of Health,
  19. (1991). A simplified general method for cluster-sample surveys of health in developing countries. World Health Stat Q
  20. (1997). An evaluation of nine commercial EIA Kits for the detection of measles specific IgG. doi
  21. (1994). Epi Info, Version 6.02: a word processing, database, and statistical program for epidemiology on microcomputers.
  22. (1993). Modeling age- and time-specific incidence from seroprevalence:toxoplasmosis. doi
  23. (1993). Modelling longitudinal toxoplasma seroprevelence in Stockholm, Sweden. Parasitol doi
  24. (1993). Statistical models in epidemiology. doi
  25. (1999). Effect of subclinical infection on maintaining immunity against measles in vaccinated children in West Africa. Lancet doi
  26. (1997). The use of mass campaigns in the expanded program on immunization: a review of reported advantages and disadvantages. doi
  27. (1997). Vaccination in pulses: a strategy for global eradication of measles and polio? Trends Microbiol doi
  28. (1998). Health Organisation. Measles in the Americas,
  29. (1998). An evaluation of oral-fluid collection devices for the determination of rubella antibody status in a rural Ethiopian community. Trans R Soc Trop Med Hyg doi
  30. (1999). Detection of measles specific IgG in oral fluid using an FITC/anti-FITC IgG capture enzyme linked immunosorbent assay (GACELISA). doi
  31. (1999). Detection of rubella virus-specific immunoglobulin G in saliva by an amplification-based enzyme-linked immunosorbent assay using monoclonal antibody to fluorescein isothiocyanate.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.